Covid-19 roundup: In­dia to re­sume vac­cine ex­ports as its own cam­paign is un­der con­trol; Pfiz­er to file for vac­cine OK in chil­dren ages 5-11

Af­ter vac­cine ex­ports were halt­ed to fo­cus on pro­vid­ing its own peo­ple with enough dos­es, In­dia will be­gin ship­ping its Covid-19 vac­cines to the Co­v­ax pro­gram again, the health min­is­ter said Mon­day.

In April, the coun­try halt­ed ship­ments as it faced a bru­tal wave of the pan­dem­ic, which saw dai­ly case num­bers sky­rock­et from around 25,000 in mid-March to more than 400,000 a day by May. Since then, how­ev­er, the vac­cine out­put has more than dou­bled, and min­is­ter Man­sukh Man­daviya said that it is set to quadru­ple to more than 300 mil­lion dos­es in Oc­to­ber. On­ly the ex­cess sup­ply will be sent to Co­v­ax, he said.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.